| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.8 | 0.002 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 7e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |